4.4 Article

Identification of a Novel de Novo p.Phe932lle KCNT1 Mutation in a Patient With Leukoencephalopathy and Severe Epilepsy

期刊

PEDIATRIC NEUROLOGY
卷 50, 期 1, 页码 112-114

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.pediatrneurol.2013.06.024

关键词

leukoencephalopathy; myoclonic; KCNT1; delayed myelination

资金

  1. National Institutes of Health, National Institute of Neurological Disorders and Stroke [1K08NS060695]
  2. Myelin Disorders Bioregistry Project
  3. ARC Discovery Early Career Research Award
  4. Institute for Molecular Bioscience core funds
  5. University of Queensland Foundation Research Excellence Award
  6. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER

向作者/读者索取更多资源

BACKGROUND: More than half of patients with genetic leukoencephalopathies remain without a specific diagnosis; this is particularly true in individuals with a likely primary neuronal etiology, such as those in which abnormal white matter occurs in combination with severe epilepsy. PATIENT: A child with a severe early infantile epileptic encephalopathy and abnormal myelination underwent whole exome sequencing. RESULTS: Whole exome sequencing identified a heterozygous de novo mutation in KCNT1, a sodium-gated potassium channel gene. CONCLUSIONS: Severely delayed myelination was anecdotally reported in previous patients with KCNT1 mutations. This case reinforces that KCNT1 sequencing should be included in an investigation of patients with severely delayed myelination and epilepsy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据